selected publications
-
academic article
- Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018.. American journal of epidemiology. 2024
- Exploring factors contributing to caregiver burden in family caregivers of congolese adults with suspected dementia.. International journal of geriatric psychiatry. 38:-. 2023
- Venous thromboembolism mortality and trends in older US adults, 2011-2019.. American journal of hematology. 98:1364-1373. 2023
- Association of Stress With Cognitive Function Among Older Black and White US Adults.. JAMA network open. 6:-. 2023
- Autoimmune disease and risk of postpartum venous thromboembolism.. Research and practice in thrombosis and haemostasis. 7:-. 2023
- Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.. Journal of the American Heart Association. 11:-. 2022
- Risk Factors for Dementia in Patients With Atrial Fibrillation.. The American journal of cardiology. 48-52. 2022
- Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.. BMC cardiovascular disorders. 21:-. 2021
- Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.. Journal of the American Heart Association. 10:-. 2021
- Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism.. Journal of the American Heart Association. 10:-. 2021
- Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis.. Research and practice in thrombosis and haemostasis. 5:-. 2021
- Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants.. Drugs - real world outcomes. 8:383-391. 2021
- Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding.. Research and practice in thrombosis and haemostasis. 5:-. 2021
- Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.. Circulation. 143:e254-e743. 2021
- Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association. Circulation. 2021
- Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism.. Vascular medicine (London, England). 25:549-556. 2020
- Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.. Journal of the American Heart Association. 9:-. 2020
- Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.. The American journal of medicine. 133:e554-e567. 2020
- Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.. JAMA internal medicine. 180:245-253. 2020
- Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.. JAMA internal medicine. 180:190-197. 2020
- Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data.. Epidemiology (Cambridge, Mass.). 30:885-892. 2019
- Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.. PloS one. 14:-. 2019
- Stroke Incidence and Survival in American Indians, Blacks, and Whites: The Strong Heart Study and Atherosclerosis Risk in Communities Study.. Journal of the American Heart Association. 8:-. 2019
- Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.. Research and practice in thrombosis and haemostasis. 3:668-673. 2019
- Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.. British journal of haematology. 185:903-911. 2019
- Geographic Disparities in the Incidence of Stroke among Patients with Atrial Fibrillation in the United States.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 28:890-899. 2018
- A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. Heart rhythm. 16:820-826. 2018
- Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.. Current medical research and opinion. 35:837-845. 2018
- Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation.. Journal of the American Heart Association. 7:-. 2018
- Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.. Journal of the American College of Cardiology. 72:1913-1922. 2018
- A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. PloS one. 13:-. 2018
- All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.. Thrombosis and haemostasis. 118:1637-1645. 2018
- Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation.. The American journal of cardiology. 122:388-394. 2018
- Ideal Cardiovascular Health and Adiposity: Implications in Youth.. Journal of the American Heart Association. 7. 2018
- Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.. Journal of the American Heart Association. 7. 2018
- Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.. Blood advances. 2:200-209. 2018
- Oral anticoagulants and liver injury: the threat of uncontrolled confounding.. Heart (British Cardiac Society). 104:-. 2018
- Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.. BMC cardiovascular disorders. 17:-. 2017
- Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 14:157-166. 2017
- Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.. Journal of cardiology. 70:99-100. 2017
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.. Heart (British Cardiac Society). 103:834-839. 2017
- Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.. Journal of cardiology. 69:868-876. 2016
- Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC).. PloS one. 11:-. 2016
- Heart Rate Variability and Incident Stroke: The Atherosclerosis Risk in Communities Study.. Stroke. 47:1452-8. 2016
- Commentary: Weight Loss and Coronary Heart Disease: Uncontrolled Confounding by Undiagnosed Disease May Not Be All It's Cracked up to Be.. Epidemiology (Cambridge, Mass.). 27:299-301. 2016
- Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study.. Sleep. 39:309-16. 2016
- Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.. International journal of cardiology. 219-23. 2015
- Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study.. JAMA internal medicine. 175:449-50. 2015
- Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.. Stroke. 45:2286-91. 2014
- Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.. PloS one. 8:-. 2013
- Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.. Circulation. Arrhythmia and electrophysiology. 5:155-62. 2012
- Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.. Circulation. Cardiovascular genetics. 4:557-64. 2011
- P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study.. Obesity (Silver Spring, Md.). 20:666-72. 2011